Article Details

Calidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial ... - BioSpace

Retrieved on: 2022-08-02 18:29:14

Tags for this article:

Click the tags to see associated articles and topics

Calidi Biotherapeutics Announces FDA Authorization of IND for a Phase 1 Clinical Trial ... - BioSpace. View article details on HISWAI: https://www.biospace.com/article/releases/calidi-biotherapeutics-announces-fda-authorization-of-ind-for-a-phase-1-clinical-trial-of-neuronova-in-patients-with-recurrent-high-grade-glioma/

Excerpt

... a clinical-stage biotechnology company that is pioneering allogeneic ... This may also result in a secondary anti-tumor immune response,” said ...

Article found on: www.biospace.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up